UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
August 11, 2009
Date of report (Date of earliest event reported)
IMAX Corporation
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
|
|
Canada
(State or Other Jurisdiction of Incorporation)
|
|
0-24216
(Commission File Number)
|
|
98-0140269
(I.R.S. Employer Identification Number) |
2525 Speakman Drive, Mississauga, Ontario, Canada, L5K 1B1
(Address of Principal Executive Offices) (Postal Code)
(905) 403-6500
(Registrants Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 1.01. Entry into a Material Definitive Agreement.
On August 11, 2009, IMAX Corporation (the Company) entered into an underwriting agreement
(the Underwriting Agreement) with Roth Capital Partners, LLC (the Underwriter) for the sale of
5,882,353 of the Companys common shares, no par value, for $8.50 per share, less the underwriting
commission. Under the terms of the Underwriting Agreement, the Company has granted the Underwriter
an option to purchase up to an additional 882,353 common shares at the public offering price, less
the underwriting commission, within 30 days from the date of the Prospectus Supplement to cover
over-allotments, if any. The offering is being made pursuant to the Companys effective
registration statement on Form S-3 (Registration Statement No. 333-157300) previously filed with
the Securities and Exchange Commission.
The foregoing summary of the Underwriting Agreement is qualified in its entirety by reference
to the actual Underwriting Agreement, which is filed as an exhibit hereto.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
|
|
|
|
Exhibit No. |
|
|
|
Description |
1.1 |
|
|
|
Underwriting Agreement, dated August 11, 2009, between IMAX
Corporation and Roth Capital Partners, LLC. |
1